. | Univariate . | Multivariate . | ||||
---|---|---|---|---|---|---|
. | Beta . | 95%CI . | P . | Beta . | 95%CI . | P . |
6-month new SCIL volume | ||||||
HALT | −0.11 | −0.37–0.14 | 0.38 | |||
CHA2DS2-VASc | 0.05 | 0.00–0.09 | 0.047 | |||
Atrial fibrillation | 0.08 | −0.07–0.23 | 0.27 | |||
6-month new WMH volume | ||||||
HALT | 0.69 | 0.08–1.32 | 0.028 | 0.79 | 0.20–1.39 | 0.009 |
CHA2DS2-VASc | 0.09 | −0.03–0.21 | 0.16 | |||
Atrial fibrillation | 0.15 | −0.03–0.34 | 0.11 | |||
Procedural SCIL volume | 0.71 | 0.53–0.89 | <0.001 | 0.58 | 0.18–1.00 | <0.001 |
. | Univariate . | Multivariate . | ||||
---|---|---|---|---|---|---|
. | Beta . | 95%CI . | P . | Beta . | 95%CI . | P . |
6-month new SCIL volume | ||||||
HALT | −0.11 | −0.37–0.14 | 0.38 | |||
CHA2DS2-VASc | 0.05 | 0.00–0.09 | 0.047 | |||
Atrial fibrillation | 0.08 | −0.07–0.23 | 0.27 | |||
6-month new WMH volume | ||||||
HALT | 0.69 | 0.08–1.32 | 0.028 | 0.79 | 0.20–1.39 | 0.009 |
CHA2DS2-VASc | 0.09 | −0.03–0.21 | 0.16 | |||
Atrial fibrillation | 0.15 | −0.03–0.34 | 0.11 | |||
Procedural SCIL volume | 0.71 | 0.53–0.89 | <0.001 | 0.58 | 0.18–1.00 | <0.001 |
HALT, hypoattenuated leaflet thickening; 6-month SCIL, silent cerebral ischaemic lesion on the 6-month MRI; 6-month new WMH, white matter hyperintensity on the 6-month MRI that was not visible at baseline.
. | Univariate . | Multivariate . | ||||
---|---|---|---|---|---|---|
. | Beta . | 95%CI . | P . | Beta . | 95%CI . | P . |
6-month new SCIL volume | ||||||
HALT | −0.11 | −0.37–0.14 | 0.38 | |||
CHA2DS2-VASc | 0.05 | 0.00–0.09 | 0.047 | |||
Atrial fibrillation | 0.08 | −0.07–0.23 | 0.27 | |||
6-month new WMH volume | ||||||
HALT | 0.69 | 0.08–1.32 | 0.028 | 0.79 | 0.20–1.39 | 0.009 |
CHA2DS2-VASc | 0.09 | −0.03–0.21 | 0.16 | |||
Atrial fibrillation | 0.15 | −0.03–0.34 | 0.11 | |||
Procedural SCIL volume | 0.71 | 0.53–0.89 | <0.001 | 0.58 | 0.18–1.00 | <0.001 |
. | Univariate . | Multivariate . | ||||
---|---|---|---|---|---|---|
. | Beta . | 95%CI . | P . | Beta . | 95%CI . | P . |
6-month new SCIL volume | ||||||
HALT | −0.11 | −0.37–0.14 | 0.38 | |||
CHA2DS2-VASc | 0.05 | 0.00–0.09 | 0.047 | |||
Atrial fibrillation | 0.08 | −0.07–0.23 | 0.27 | |||
6-month new WMH volume | ||||||
HALT | 0.69 | 0.08–1.32 | 0.028 | 0.79 | 0.20–1.39 | 0.009 |
CHA2DS2-VASc | 0.09 | −0.03–0.21 | 0.16 | |||
Atrial fibrillation | 0.15 | −0.03–0.34 | 0.11 | |||
Procedural SCIL volume | 0.71 | 0.53–0.89 | <0.001 | 0.58 | 0.18–1.00 | <0.001 |
HALT, hypoattenuated leaflet thickening; 6-month SCIL, silent cerebral ischaemic lesion on the 6-month MRI; 6-month new WMH, white matter hyperintensity on the 6-month MRI that was not visible at baseline.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.